Whole-Exome Sequencing Reveals Clinical Potential of Circulating Tumor DNA from Peritoneal Fluid and Plasma in Endometrial Cancer

Endometrial cancer (EC) is the most common type of gynecological cancer. Studies comparing tumor gDNA and ctDNA isolated from the plasma and peritoneal fluid of EC patients are limited. Whole-exome sequencing and P53 immunohistochemistry of 24 paired tissue, plasma, and peritoneal fluid samples from...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2022-05, Vol.14 (10), p.2506
Main Authors: Ju, Hye-Yeon, Ho, Jung Yoon, Kang, Jun, Hur, Soo Young, Kim, Sejin, Choi, Youn Jin, Han, Mi-Ryung
Format: Article
Language:English
Subjects:
Algorithms
Biomarkers
Biopsy
Cancer
Cellular biology
Copy number
Cytology
Deoxyribonucleic acid
DNA
Endometrial cancer
Endometrium
Genes
Genomes
Immunohistochemistry
Microsatellite instability
Mutation
p53 Protein
Patients
Peritoneal fluid
Peritoneum
Plasma
PTEN protein
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Endometrial cancer (EC) is the most common type of gynecological cancer. Studies comparing tumor gDNA and ctDNA isolated from the plasma and peritoneal fluid of EC patients are limited. Whole-exome sequencing and P53 immunohistochemistry of 24 paired tissue, plasma, and peritoneal fluid samples from 10 EC patients were performed to analyze somatic mutations, copy number alterations, microsatellite instability, and mutational signatures. Mutations in cancer-related genes ( , , , , and ) and genes related to EC ( , , , and ) were identified with high frequencies among the three samples. and mutations, which are highly related to the molecular classification of EC, were identified based on several key observations. The ctDNA of two patients with negative peritoneal fluid presented mutations concordant with those in tissues. ctDNA from the plasma and peritoneal fluid of a patient with positive cytology harbored both and mutations, although none were detected in tissues. Additionally, the patient presented with wild type P53 immunohistochemistry, with a focal "high" expression in a "low" wild type background. The tissues and peritoneal fluid of 75% EC patients showed concordant microsatellite instability. Furthermore, we observed strong mutational concordance between the peritoneal fluid and tumors. Our data suggest that the ctDNA from peritoneal fluid might be a suitable biomarker for identifying the mutational landscape of EC and could complement tumor heterogeneity.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers14102506